Am J Epidemiol 2003; 157:113-120.
Copyright © 2003 by Johns
Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Body Mass Index at Age 18 Years and during Adult Life and Ovarian Cancer Risk
1 Cancer Epidemiology Unit, Gertner Institute, Sheba Medical Center, Tel Hashomer, Israel.
2 Biostatistics Unit, Gertner Institute, Sheba Medical Center, Tel Hashomer, Israel, and Bar Ilan University, Ramat Gan, Israel.
3 School of Allied Health Sciences, Ariel College, Ariel, Israel.
4 Stanley Steyer Institute for Cancer Epidemiology and Research, Tel Aviv University Medical School, Tel Aviv, Israel.
During the years 1994–1999, a nationwide ovarian cancer case-control study was conducted in Israel. The present analysis addresses the question: Is epithelial ovarian cancer associated with body mass index at age 18 years and/or with weight changes in body mass index between adolescence and adult life? The study is based on 1,269 women with epithelial ovarian cancer and 2,111 matched controls. A significant decrease in risk of ovarian cancer was observed with parity, oral contraceptive use, and postmenopausal status. A significant increase in risk with family history of ovarian/breast cancer was also found. No significant association with age at menarche or infertility was found. For body mass index at age 18 years, the odds ratio of the highest versus lowest body mass index quartile was 1.42 (95% confidence interval: 1.08, 1.85) and after adjusting for confounders was 1.54 (95% confidence interval: 1.17, 2.02). However, no statistically significant risk associated with change in weight from age 18 years to adult life was found. The authors conclude that, in their population, body mass index at age 18 years is an independent risk factor for ovarian cancer.
body mass index; ovarian neoplasms; risk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. K. Kumanyika, E. Obarzanek, N. Stettler, R. Bell, A. E. Field, S. P. Fortmann, B. A. Franklin, M. W. Gillman, C. E. Lewis, W. C. Poston II, et al. Population-Based Prevention of Obesity: The Need for Comprehensive Promotion of Healthful Eating, Physical Activity, and Energy Balance: A Scientific Statement From American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (Formerly the Expert Panel on Population and Prevention Science) Circulation, July 22, 2008; 118(4): 428 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Schouten, C. Rivera, D. J. Hunter, D. Spiegelman, H.-O. Adami, A. Arslan, W. L. Beeson, P. A. van den Brandt, J. E. Buring, A. R. Folsom, et al. Height, Body Mass Index, and Ovarian Cancer: A Pooled Analysis of 12 Cohort Studies Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 902 - 912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Lane Obesity and gynaecological cancer Menopause Int, March 1, 2008; 14(1): 33 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Beehler, M. Sekhon, J. A. Baker, B. E. Teter, S. E. McCann, K. J. Rodabaugh, and K. B. Moysich Risk of Ovarian Cancer Associated with BMI Varies by Menopausal Status J. Nutr., November 1, 2006; 136(11): 2881 - 2886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Lubin, A. Chetrit, B. Modan, and L. S. Freedman Dietary Intake Changes and Their Association with Ovarian Cancer Risk J. Nutr., September 1, 2006; 136(9): 2362 - 2367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lukanova and R. Kaaks Endogenous Hormones and Ovarian Cancer: Epidemiology and Current Hypotheses Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 98 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Engeland, S. Tretli, and T. Bjorge Height, Body Mass Index, and Ovarian Cancer: A Follow-Up of 1.1 Million Norwegian Women J Natl Cancer Inst, August 20, 2003; 95(16): 1244 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Rutter, S. Wacholder, A. Chetrit, F. Lubin, J. Menczer, S. Ebbers, M. A. Tucker, J. P. Struewing, and P. Hartge Gynecologic Surgeries and Risk of Ovarian Cancer in Women With BRCA1 and BRCA2 Ashkenazi Founder Mutations: An Israeli Population-Based Case-Control Study J Natl Cancer Inst, July 16, 2003; 95(14): 1072 - 1078. [Abstract] [Full Text] [PDF]
|
|